Anti-TNF certolizumab pegol induces antioxidant response in human monocytes via reverse signaling
- DOI
- 10.1186/s13075-016-0955-8
- Published
- 2016-03-01
- Container
- Arthritis Research & Therapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s13075-016-0955-8,
title = {Anti-TNF certolizumab pegol induces antioxidant response in human monocytes via reverse signaling},
author = {Jean Frédéric Boyer and Michel Baron and Arnaud Constantin and Yannick Degboé and Alain Cantagrel and Jean-Luc Davignon},
year = {2016},
journal = {Arthritis Research \& Therapy},
doi = {10.1186/s13075-016-0955-8},
url = {https://doi.org/10.1186/s13075-016-0955-8}
}RIS
TY - JOUR TI - Anti-TNF certolizumab pegol induces antioxidant response in human monocytes via reverse signaling AU - Jean Frédéric Boyer AU - Michel Baron AU - Arnaud Constantin AU - Yannick Degboé AU - Alain Cantagrel AU - Jean-Luc Davignon PY - 2016 JO - Arthritis Research & Therapy DO - 10.1186/s13075-016-0955-8 UR - https://doi.org/10.1186/s13075-016-0955-8 ER -
APA
Boyer, J. F., Baron, M., Constantin, A., Degboé, Y., Cantagrel, A., & Davignon, J. (2016). Anti-TNF certolizumab pegol induces antioxidant response in human monocytes via reverse signaling. Arthritis Research & Therapy. https://doi.org/10.1186/s13075-016-0955-8
Source records
- crossref · retrieved 2026-09-25T20:30:10.939Z